Overview
Pharmacokinetics and Safety of DWJ1451 in Healthy Adults
Status:
Enrolling by invitation
Enrolling by invitation
Trial end date:
2021-04-02
2021-04-02
Target enrollment:
0
0
Participant gender:
All
All
Summary
Amlodipine, olmesartan, total ezetimibe, rosuvastatin AUCt, CmaxPhase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Criteria
Inclusion Criteria:- Age 19 to 55 years
- Healthy Adult
Exclusion Criteria:
- Non-Healthy